Pharmacy bag

Genstar Capital sells Evolution1 to WEX Inc for USD532.5m

Private equity firm Genstar Capital is to sell Evolution1, a specialist in consumer directed health (CDH) payments and technology, to WEX Inc for USD532.5 million.

Evolution1 provides software, payment and mobile solutions that administer and manage consumer directed healthcare accounts. The company's administrative software solutions, driven by patented technology, allow more than 10 million consumers to spend electronically through prepaid funds in CDH accounts such as Health Spending Accounts (HSAs), Flexible Spending Accounts (FSAs), Defined Contribution, and more. 
 
Evolution1's cloud-based solutions provide a single end-to-end user experience that reduces costs, saves time and simplifies the business of healthcare. Through its 1Plan by Evolution1 offering, Evolution1 is a leading technology provider to Defined Contribution health plans and private exchanges. 
 
WEX represents more than 7.8 million cardholders and offers payment security and control across a wide spectrum of business sectors. Headquartered in South Portland, Maine, WEX has an additional 10 offices in the US and abroad. The company employs 1,400 associates.
 
Eli Weiss, a principal at Genstar, says: "Evolution1 is an industry leader with a bright future. During Genstar's ownership, Evolution1 developed and expanded its solutions to achieve strong organic growth.  The company today serves more than 10 million consumers and more than 90,000 employer groups.  The platform is poised to continue building on this momentum, and we are pleased to have worked with this talented senior management team to dramatically grow this business.  It is gratifying that WEX sees the continued exciting growth prospects for Evolution1."
 
Jeff Young, chairman and chief executive officer of Evolution1, says: "All of our core solutions have demonstrated consistent growth as we continue to build key relationships and sign multi-year partnerships with large health plans, banks, payroll providers, private exchanges, and leading third-party administrators.  Our success is a result of our ability to help our partners simplify the healthcare experience for millions of employers and consumers, and we are pleased to have worked with the Genstar team who were instrumental to this successful outcome."
 
The pending sale of Evolution1 follows the successful realisations this year from Genstar's software investment platform of TravelClick, a provider of innovative cloud-based software solutions to the hospitality industry, for USD930 million and ConvergeOne, an independent provider of innovative communications solutions and managed services to enterprises globally.
 
"The successful investment in Evolution1 is another strong example of Genstar's ability to transform businesses into innovative industry leaders," says Jean-Pierre L Conte, chairman and managing director of Genstar Capital. "Evolution1 is particularly exciting as we coordinated our sector specialisation from multiple industry disciplines – healthcare, software, and financial services – to build and grow this tremendous company.  We are delighted to have worked with the Evolution1 management team, as this transaction marks an exciting moment and a successful exit for Genstar."

Further reading



Upcoming events

5 hours 59 min from now - London
5 hours 59 min from now - Shanghai
5 hours 59 min from now - Dubai
5 hours 59 min from now - Hong Kong
5 hours 59 min from now - New York

Upcoming training

Mon, 10/11/2014 (All day) - London
Mon, 10/11/2014 (All day) - London
Thu, 13/11/2014 (All day) - London